Editorial Standards & Research Methodology
PeptidePlaza operates as an open scientific reference database. We apply rigorous biomedical indexing criteria to ensure every data point, sequence, half-life, and clinical trial outcome is supported by primary peer-reviewed literature.
1. Primary Literature & Citation Standards
Every factual statement, receptor affinity, and pharmacokinetic value indexed in our encyclopedia traces to primary biomedical literature. Our research desk indexes studies directly from the National Center for Biotechnology Information (NCBI PubMed), PubMed Central (PMC), PubChem, and major peer-reviewed journals (NEJM, Lancet, Nature, Cell Metabolism).
- Prioritization of Randomized Controlled Trials (RCTs), systematic reviews, and meta-analyses over animal models.
- All citations link directly to permanent DOI or PubMed identifiers (PMIDs).
- Clear distinction between in vitro assays, animal studies, and human clinical trials.
2. Analytical Verification & COA Standards
In research chemistry, analytical transparency is paramount. We publish no supplier listings, but the standards below are how analytical documentation should be read when you evaluate any source yourself:
HPLC Purity Analysis
High-Performance Liquid Chromatography reports must demonstrate chromatogram peak purity exceeding 98.0% for research-grade materials.
Mass Spectrometry (MS)
Electrospray ionization (ESI-MS) or MALDI-TOF confirmation matching the theoretical molecular weight of the peptide sequence.
3. Scientific Disclaimers & Regulatory Transparency
PeptidePlaza provides chemical reference data, molecular structures, and study summaries for educational and laboratory research purposes. Unlicensed peptides are not approved for human therapeutic use or diagnosis. We provide unambiguous regulatory classifications (FDA Approved, Phase 1–3, or Investigational) for every listed entity.